FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, in particular to experimental cardiopharmacology and can be used for correction of hyperhomocystein-induced endothelial dysfunction by mixture of solutions of homeopathic dilutions of polyclonal rabbit antibodies to human endothelial nitrogen oxide synthgase - C12, C30, C200. Method of correction of hyperhomocystein-induced endothelial dysfunction lies in the following: in experiment male rats of line Wistar for 7 days, at the background of intragastric introduction of methionine in dose 3 g/kg, daily, I time per day by addition into drinking bowls to drink introduced is mixture of solutions of homeopathic dilutions of polyclonal rabbit antibodies to human endothelial nitrogen oxide synthgase - C12, C30, C200.
EFFECT: method makes it possible to reduce coefficient of endothelial dysfunction.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH LOZARTAN IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2437162C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES | 2011 |
|
RU2477529C2 |
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH ENALAPRIL IN COMPLEX WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438189C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH SOLVENT MIXTURE OF HOMEOPATHIC DILUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE C12, C30, C200 | 2006 |
|
RU2306953C1 |
METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438191C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING LOZARTAN IN COMPLEX WITH ADMIXTURE OF SOLUTIONS OF HOMEOPATHIC DELUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO ENDOTHELIAL SYNTHASE OF HUMAN NITROGEN OXIDE-C12, C30, C200 | 2007 |
|
RU2343927C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF TUMOUR NECROSIS FACTOR ALPHA ANTIBODIES | 2011 |
|
RU2478233C2 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES | 2011 |
|
RU2526151C2 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-6 ANTIBODIES | 2011 |
|
RU2477530C2 |
Authors
Dates
2011-08-10—Published
2010-04-12—Filed